Healthcare & Pharmaceuticals

With companies eager to tout their "green" credentials to consumers, advertising watchdogs are stepping up efforts to rein in marketers that make false or exaggerated claims.
While 25 million Africans are living with AIDS, Northern pharmaceutical companies and governments are turning their back on the greatest tragedy of our time according to former deputy head of UNICEF.
In the final hectic days before Congress adjourns for the year, lobbyists are swarming around the Capitol, trying to adorn a bill on bioterrorism with all sorts of special-interest provisions.
Bayer doesn't just make aspirin--it's a major producer of chemicals and drugs with a dubious corporate record. So how did it get into a partnership with the UN? A German activist tells how and why.
39 NGOs Denounce 39 Pharmaceutical Transnationals' Legal Action Against the South African Government and the Complaint Against Brazil Lodged by the USA with WTO.
The HRT (Hormone Replacement Therapy) scandal is bigger than most think. It's not just about menopausal women, like me, getting bad information from their physicians and the pharmaceutical industry for over 40 years, while the federal government stood by and did nothing. The scandal is much bigger than that.
Drugmaker Merck & Co.'s research facility in West Point dumped a chemical compound that included cyanide into the sewer system, killing more than 1,000 fish in Wissahickon Creek, federal authorities said Thursday.
CrocTail is an extension of the Crocodyl.org Wiki web site project, an online compendium profiling the accountability and transparency track records of multinational corporations. Developed with support from the Sunlight Foundation, CrocTail users can search the entire subsidiaries database. In this new version, users can click on different years and see how subsidiary relationships for a company have changed over time.
Perhaps that was going through the mind of executives at AstraZeneca, the drug manufacturer, when they decided to invent National Breast Cancer Awareness Month.
International drugs companies should seek to reduce prices for medicines sold to the poorest countries and avoid filing for patent protection there, a report prepared for the World Health Organisation (WHO) said on Monday.